Report Detail

Request for Sample of this report

Medical Devices & Consumables Global Blood Tests for Alzheimer's Diagnosis Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4710891
    • |
  • 05 October, 2026
    • |
  • Global
    • |
  • 104 Pages
    • |
  • GIR
    • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Blood Tests for Alzheimer's Diagnosis market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Blood tests for Alzheimer's diagnosis are emerging as a promising tool for early detection and monitoring of the disease. These tests aim to identify biomarkers associated with Alzheimer's, such as amyloid-beta and tau proteins, which are indicators of the characteristic plaques and tangles in the brain. Advances in technology have made it possible to measure these proteins with high sensitivity and specificity in the blood. This non-invasive approach offers a more accessible, cost-effective, and less burdensome alternative to traditional methods like cerebrospinal fluid analysis and neuroimaging. Blood tests can aid in early diagnosis, potentially leading to earlier intervention and better management of Alzheimer's disease.
This report is a detailed and comprehensive analysis for global Blood Tests for Alzheimer's Diagnosis market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Blood Tests for Alzheimer's Diagnosis market size and forecasts, in consumption value ($ Million), 2021-2032
Global Blood Tests for Alzheimer's Diagnosis market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Blood Tests for Alzheimer's Diagnosis market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Blood Tests for Alzheimer's Diagnosis market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Blood Tests for Alzheimer's Diagnosis
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Blood Tests for Alzheimer's Diagnosis market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Quanterix, Quest Diagnostics, C₂N Diagnostics, Fujirebio, Diadem, Labcorp, Neurocode, Cognitact, Vazyme International, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Blood Tests for Alzheimer's Diagnosis market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Single Molecule Immunoassay Array Analysis
Chemiluminescence Method
Fluorescence PCR Method
Others
Market segment by Application
Clinical Diagnosis
Research
Market segment by players, this report covers
Roche
Quanterix
Quest Diagnostics
C₂N Diagnostics
Fujirebio
Diadem
Labcorp
Neurocode
Cognitact
Vazyme International
KingMed Diagnostics
Hoyotek
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Blood Tests for Alzheimer's Diagnosis product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Blood Tests for Alzheimer's Diagnosis, with revenue, gross margin, and global market share of Blood Tests for Alzheimer's Diagnosis from 2021 to 2026.
Chapter 3, the Blood Tests for Alzheimer's Diagnosis competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Blood Tests for Alzheimer's Diagnosis market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Blood Tests for Alzheimer's Diagnosis.
Chapter 13, to describe Blood Tests for Alzheimer's Diagnosis research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Blood Tests for Alzheimer's Diagnosis by Type
    • 1.3.1 Overview: Global Blood Tests for Alzheimer's Diagnosis Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Type in 2025
    • 1.3.3 Single Molecule Immunoassay Array Analysis
    • 1.3.4 Chemiluminescence Method
    • 1.3.5 Fluorescence PCR Method
    • 1.3.6 Others
  • 1.4 Global Blood Tests for Alzheimer's Diagnosis Market by Application
    • 1.4.1 Overview: Global Blood Tests for Alzheimer's Diagnosis Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Clinical Diagnosis
    • 1.4.3 Research
  • 1.5 Global Blood Tests for Alzheimer's Diagnosis Market Size & Forecast
  • 1.6 Global Blood Tests for Alzheimer's Diagnosis Market Size and Forecast by Region
    • 1.6.1 Global Blood Tests for Alzheimer's Diagnosis Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Blood Tests for Alzheimer's Diagnosis Market Size by Region, (2021-2032)
    • 1.6.3 North America Blood Tests for Alzheimer's Diagnosis Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Blood Tests for Alzheimer's Diagnosis Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Blood Tests for Alzheimer's Diagnosis Market Size and Prospect (2021-2032)
    • 1.6.6 South America Blood Tests for Alzheimer's Diagnosis Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Roche
    • 2.1.1 Roche Details
    • 2.1.2 Roche Major Business
    • 2.1.3 Roche Blood Tests for Alzheimer's Diagnosis Product and Solutions
    • 2.1.4 Roche Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Roche Recent Developments and Future Plans
  • 2.2 Quanterix
    • 2.2.1 Quanterix Details
    • 2.2.2 Quanterix Major Business
    • 2.2.3 Quanterix Blood Tests for Alzheimer's Diagnosis Product and Solutions
    • 2.2.4 Quanterix Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Quanterix Recent Developments and Future Plans
  • 2.3 Quest Diagnostics
    • 2.3.1 Quest Diagnostics Details
    • 2.3.2 Quest Diagnostics Major Business
    • 2.3.3 Quest Diagnostics Blood Tests for Alzheimer's Diagnosis Product and Solutions
    • 2.3.4 Quest Diagnostics Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Quest Diagnostics Recent Developments and Future Plans
  • 2.4 C₂N Diagnostics
    • 2.4.1 C₂N Diagnostics Details
    • 2.4.2 C₂N Diagnostics Major Business
    • 2.4.3 C₂N Diagnostics Blood Tests for Alzheimer's Diagnosis Product and Solutions
    • 2.4.4 C₂N Diagnostics Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 C₂N Diagnostics Recent Developments and Future Plans
  • 2.5 Fujirebio
    • 2.5.1 Fujirebio Details
    • 2.5.2 Fujirebio Major Business
    • 2.5.3 Fujirebio Blood Tests for Alzheimer's Diagnosis Product and Solutions
    • 2.5.4 Fujirebio Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Fujirebio Recent Developments and Future Plans
  • 2.6 Diadem
    • 2.6.1 Diadem Details
    • 2.6.2 Diadem Major Business
    • 2.6.3 Diadem Blood Tests for Alzheimer's Diagnosis Product and Solutions
    • 2.6.4 Diadem Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Diadem Recent Developments and Future Plans
  • 2.7 Labcorp
    • 2.7.1 Labcorp Details
    • 2.7.2 Labcorp Major Business
    • 2.7.3 Labcorp Blood Tests for Alzheimer's Diagnosis Product and Solutions
    • 2.7.4 Labcorp Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Labcorp Recent Developments and Future Plans
  • 2.8 Neurocode
    • 2.8.1 Neurocode Details
    • 2.8.2 Neurocode Major Business
    • 2.8.3 Neurocode Blood Tests for Alzheimer's Diagnosis Product and Solutions
    • 2.8.4 Neurocode Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Neurocode Recent Developments and Future Plans
  • 2.9 Cognitact
    • 2.9.1 Cognitact Details
    • 2.9.2 Cognitact Major Business
    • 2.9.3 Cognitact Blood Tests for Alzheimer's Diagnosis Product and Solutions
    • 2.9.4 Cognitact Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Cognitact Recent Developments and Future Plans
  • 2.10 Vazyme International
    • 2.10.1 Vazyme International Details
    • 2.10.2 Vazyme International Major Business
    • 2.10.3 Vazyme International Blood Tests for Alzheimer's Diagnosis Product and Solutions
    • 2.10.4 Vazyme International Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Vazyme International Recent Developments and Future Plans
  • 2.11 KingMed Diagnostics
    • 2.11.1 KingMed Diagnostics Details
    • 2.11.2 KingMed Diagnostics Major Business
    • 2.11.3 KingMed Diagnostics Blood Tests for Alzheimer's Diagnosis Product and Solutions
    • 2.11.4 KingMed Diagnostics Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 KingMed Diagnostics Recent Developments and Future Plans
  • 2.12 Hoyotek
    • 2.12.1 Hoyotek Details
    • 2.12.2 Hoyotek Major Business
    • 2.12.3 Hoyotek Blood Tests for Alzheimer's Diagnosis Product and Solutions
    • 2.12.4 Hoyotek Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Hoyotek Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Blood Tests for Alzheimer's Diagnosis Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Blood Tests for Alzheimer's Diagnosis by Company Revenue
    • 3.2.2 Top 3 Blood Tests for Alzheimer's Diagnosis Players Market Share in 2025
    • 3.2.3 Top 6 Blood Tests for Alzheimer's Diagnosis Players Market Share in 2025
  • 3.3 Blood Tests for Alzheimer's Diagnosis Market: Overall Company Footprint Analysis
    • 3.3.1 Blood Tests for Alzheimer's Diagnosis Market: Region Footprint
    • 3.3.2 Blood Tests for Alzheimer's Diagnosis Market: Company Product Type Footprint
    • 3.3.3 Blood Tests for Alzheimer's Diagnosis Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Blood Tests for Alzheimer's Diagnosis Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Blood Tests for Alzheimer's Diagnosis Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Blood Tests for Alzheimer's Diagnosis Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2021-2032)
  • 6.2 North America Blood Tests for Alzheimer's Diagnosis Market Size by Application (2021-2032)
  • 6.3 North America Blood Tests for Alzheimer's Diagnosis Market Size by Country
    • 6.3.1 North America Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2021-2032)
    • 6.3.2 United States Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2021-2032)
  • 7.2 Europe Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2021-2032)
  • 7.3 Europe Blood Tests for Alzheimer's Diagnosis Market Size by Country
    • 7.3.1 Europe Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
    • 7.3.3 France Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Blood Tests for Alzheimer's Diagnosis Market Size by Region
    • 8.3.1 Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value by Region (2021-2032)
    • 8.3.2 China Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
    • 8.3.5 India Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2021-2032)
  • 9.2 South America Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2021-2032)
  • 9.3 South America Blood Tests for Alzheimer's Diagnosis Market Size by Country
    • 9.3.1 South America Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size by Country
    • 10.3.1 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Blood Tests for Alzheimer's Diagnosis Market Drivers
  • 11.2 Blood Tests for Alzheimer's Diagnosis Market Restraints
  • 11.3 Blood Tests for Alzheimer's Diagnosis Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Blood Tests for Alzheimer's Diagnosis Industry Chain
  • 12.2 Blood Tests for Alzheimer's Diagnosis Upstream Analysis
  • 12.3 Blood Tests for Alzheimer's Diagnosis Midstream Analysis
  • 12.4 Blood Tests for Alzheimer's Diagnosis Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Blood Tests for Alzheimer's Diagnosis. Industry analysis & Market Report on Blood Tests for Alzheimer's Diagnosis is a syndicated market report, published as Global Blood Tests for Alzheimer's Diagnosis Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Blood Tests for Alzheimer's Diagnosis market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo